2JMB

Solution structure of the protein Atu4866 from Agrobacterium tumefaciens

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O	90% H2O/10% D2O	0.45	5.0	1 atm	298
2	2D 1H-13C HSQC	0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O	90% H2O/10% D2O	0.45	5.0	1 atm	298
3	3D CBCA(CO)NH	0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O	90% H2O/10% D2O	0.45	5.0	1 atm	298
4	3D C(CO)NH	0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O	90% H2O/10% D2O	0.45	5.0	1 atm	298
5	3D HNCO	0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O	90% H2O/10% D2O	0.45	5.0	1 atm	298
6	3D HNCACB	0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O	90% H2O/10% D2O	0.45	5.0	1 atm	298
7	3D H(CCO)NH	0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O	90% H2O/10% D2O	0.45	5.0	1 atm	298
8	3D HCCH-TOCSY	0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O	90% H2O/10% D2O	0.45	5.0	1 atm	298
9	3D HNHA	0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O	90% H2O/10% D2O	0.45	5.0	1 atm	298
10	3D 1H-15N NOESY	0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O	90% H2O/10% D2O	0.45	5.0	1 atm	298
11	3D 1H-13C NOESY	0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O	90% H2O/10% D2O	0.45	5.0	1 atm	298
12	3D aromatic 1H-13C NOESY	0.4 mM [U-13C, U-15N] Atu4866, 10 mM sodium acetate, 300 mM NaCl, 10 uM Zn2+, 10 mM DTT, 0.01% NaN3, 1x v/v inhibitor mixture, 10 mM benzamidine, 90% H2O, 10% D2O	90% H2O/10% D2O	0.45	5.0	1 atm	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600

NMR Refinement
Method	Details	Software
simulated annealing, torsion angle dynamics		NMRView

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	20
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	data analysis	NMRView	5.2.2	Johnson
2	structure solution	CNS	1.1	Brunger, Adams, Clore, Gros, Nilges and Read
3	refinement	CNS	1.1	Brunger, Adams, Clore, Gros, Nilges and Read